These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 15547876)

  • 1. [Anti-cytokine therapy: present status and future perspectives in nephrology].
    Panichi V; Paoletti S
    G Ital Nefrol; 2004; 21(5):446-53. PubMed ID: 15547876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cytokine Ab immune therapy: present status and perspectives.
    Zagury D; Gallo RC
    Drug Discov Today; 2004 Jan; 9(2):72-81. PubMed ID: 15012931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal healing with thalidomide in refractory Crohn's disease patients intolerant of anti-TNF-α drugs: report of 3 cases and literature review.
    Scribano ML; Cantoro L; Marrollo M; Cosintino R; Kohn A
    J Clin Gastroenterol; 2014 Jul; 48(6):530-3. PubMed ID: 24667589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease.
    Mansfield JC; Parkes M; Hawthorne AB; Forbes A; Probert CS; Perowne RC; Cooper A; Zeldis JB; Manning DC; Hawkey CJ
    Aliment Pharmacol Ther; 2007 Aug; 26(3):421-30. PubMed ID: 17635377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential mechanisms of benefit with thalidomide in chronic heart failure.
    Aukrust P; Yndestad A; Damås JK; Ueland T; Øie E; Gullestad L
    Am J Cardiovasc Drugs; 2007; 7(2):127-34. PubMed ID: 17503883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current role of thalidomide in HIV-positive patients with recurrent aphthous ulcerations.
    Shetty K
    Gen Dent; 2007; 55(6):537-42. PubMed ID: 18050580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal antibodies in chronic autoimmune inflammatory diseases].
    Semerano L; Boissier MC
    Med Sci (Paris); 2009 Dec; 25(12):1108-12. PubMed ID: 20035687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of experimental colitis by thalidomide.
    Kenet G; Wardi J; Avni Y; Aeed H; Shirin H; Zaidel L; Hershkoviz R; Bruck R
    Isr Med Assoc J; 2001 Sep; 3(9):644-8. PubMed ID: 11574978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of thalidomide resistant pyoderma gangrenosum with etenercept.
    Guedes R; Moreira A; Menezes N; Baptista A; Varela P
    Acta Dermatovenerol Croat; 2012; 20(3):175-80. PubMed ID: 23069303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thalidomide: new uses for an old drug].
    Wu KL; Sonneveld P
    Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cytokines in the treatment of cancer cachexia.
    Prado BL; Qian Y
    Ann Palliat Med; 2019 Jan; 8(1):67-79. PubMed ID: 30180740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
    Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
    Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thalidomide saga.
    Melchert M; List A
    Int J Biochem Cell Biol; 2007; 39(7-8):1489-99. PubMed ID: 17369076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of thalidomide administration in patients with neoplastic diseases.
    Dimopoulos MA; Eleutherakis-Papaiakovou V
    Am J Med; 2004 Oct; 117(7):508-15. PubMed ID: 15464708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel potential uses of thalidomide in the management of pain? A review of the literature].
    Peuckmann V; Strumpf M; Zenz M; Bruera E
    Schmerz; 2003 Jun; 17(3):204-10. PubMed ID: 12789488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic role of thalidomide in inflammatory bowel disease.
    Casella G; De Marco E; Monti C; Baldini V
    Minerva Gastroenterol Dietol; 2006 Sep; 52(3):293-301. PubMed ID: 16971873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide. A surprising recovery.
    Stirling D; Sherman M; Strauss S
    J Am Pharm Assoc (Wash); 1997; NS37(3):306-13. PubMed ID: 9170807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial.
    Drenth JP; Vonk AG; Simon A; Powell R; van der Meer JW
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1221-6. PubMed ID: 11504824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide attenuates excessive inflammation without interrupting lipopolysaccharide-driven inflammatory cytokine production in chronic granulomatous disease.
    Kawai T; Watanabe N; Yokoyama M; Arai K; Oana S; Harayama S; Yasui K; Oh-Ishi T; Onodera M
    Clin Immunol; 2013 May; 147(2):122-8. PubMed ID: 23583898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatologic and nondermatologic uses of thalidomide.
    Nasca MR; Micali G; Cheigh NH; West LE; West DP
    Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.